keyword
https://read.qxmd.com/read/37756537/remission-after-rituximab-for-hhv8-mcd-what-next
#21
EDITORIAL
Ramya Ramaswami, Thomas S Uldrick
No abstract text is available yet for this article.
September 26, 2023: Blood Advances
https://read.qxmd.com/read/37661598/a-case-of-cutaneous-malignant-glomus-tumor
#22
Sebastian Senff, Thomas P Orschulok, Duncan L Lambie, Fiona Lehane
Glomus tumors are well-known but relatively rare vascular neoplasms, with their malignant counterparts still being rarer. There are very few reports of cutaneous malignant glomus tumors, and the current limited evidence suggests that they follow a more indolent course than deep-seated malignant glomus tumors. Herein, we are reporting a case of cutaneous malignant glomus tumor. A 94-year-old male presented with a right-sided ulcerated scalp lesion, which, on biopsy, showed a diffusely infiltrative epithelioid malignancy with considerable pleomorphism and a notable perivascular growth pattern...
September 3, 2023: Journal of Cutaneous Pathology
https://read.qxmd.com/read/37634492/a-multicentric-castleman-disease-associated-with-mixed-warm-and-cold-antibody-mediated-aha-responsive-to-siltuximab
#23
Federica Plano, Salvatrice Mancuso, Giulia Maria Camarda, Maria Giulia Butera, Giuseppe Sucato, Giuseppe Alecci, Ada Maria Florena, Salvatore Perrone, Sergio Mario Siragusa
Castleman disease (CD) is nonclonallymphoproliferative disorders defined by hypertrophy of lymph nodes. The multicentric form (MCD), in which multiple lymph node stations are involved, is not associated with HHV8 infection, but considered idiopathic, although IL-6 appears to play a central role in its pathogenesis. Here we report the case of a patient that presented with mixed AIHA and adenopathy, that was very challenging to diagnose due to very low values of hemoglobin and refractoriness of obtaining any improvement of AIHA with standard first and second lines of therapy (steroids, rituximab, immunoglobulin, erythropoietin, and cyclosporine)...
August 25, 2023: Chemotherapy
https://read.qxmd.com/read/37605703/a-challenging-case-of-kaposi-sarcoma-inflammatory-cytokine-syndrome
#24
Ammar Al-Obaidi, Himil Mahadevia, Zain Syed, Shahzad Raza
Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS) is a serious, uncommon disease that occurs in patients who are positive for HIV and human herpesvirus-8 (HHV-8). It is characterized by a constellation of clinical findings, including fever, weight loss, and fluid retention, as well as a lack of multicentric Castleman disease (MCD) features on histopathology and an elevated serum HHV-8 viral load. Diagnosis is often delayed, and treatment options are limited, culminating in high mortality rates. We hereby present a 32-year-old male patient with HIV who was untreated for a few years and came with fever, night sweats, pancytopenia, and widespread adenopathy...
July 2023: Curēus
https://read.qxmd.com/read/37561194/lymphomas-with-plasmablastic-features-a-report-of-the-lymphoma-workshop-of-the-20th-meeting-of-the-european-association-for-haematopathology
#25
JOURNAL ARTICLE
Snjezana Dotlic, Sarah E Gibson, Sylvia Hartmann, Eric D Hsi, Monika Klimkowska, Socorro Maria Rodriguez-Pinilla, Elena Sabattini, Thomas A Tousseyn, Daphne de Jong, Stefan Dojcinov
Lymphomas with plasmablastic features are a heterogeneous group of aggressive and mostly uncommon neoplasms of varied aetiologies, presenting in immunocompetent individuals as well as in immunodeficiency, associated with EBV and Kaposi sarcoma virus infections, and some as progression from indolent B-cell lymphomas. They show overlapping diagnostic features and pose a differential diagnosis with other aggressive B-cell lymphomas that can downregulate the B-cell expression programme. The spectrum of rare reactive proliferations and all lymphomas defined by plasmablastic features, together with an expanding range of poorly characterised, uncommon conditions at the interface between reactive lymphoid proliferations and neoplasia submitted to the session V of the 20th European Association for Haematopathology/Society for Hematopathology lymphoma workshop are summarised and discussed in this paper...
August 10, 2023: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/37555981/cavity-based-lymphomas-challenges-and-novel-concepts-a-report-of-the-2022-ea4hp-sh-lymphoma-workshop
#26
JOURNAL ARTICLE
Arianna Di Napoli, Lori Soma, Leticia Quintanilla-Martinez, Laurence de Leval, Lorenzo Leoncini, Alberto Zamò, Siok-Bian Ng, Sarah L Ondrejka, Fina Climent, Andrew Wotherspoon, Stefan Dirnhofer
The 2022 European Association for Haematopathology/Society for Hematopathology lymphoma workshop session on cavity-based lymphomas included sixty-eight cases in seven sections. The disease entities discussed include primary effusion lymphomas (PEL), extracavitary primary effusion lymphomas and confounding entities (ECPEL), HHV8-negative B-lineage lymphomas-effusion based (EBV-negative, EBV-positive, and plasmablastic types), diffuse large B-cell lymphoma associated with chronic inflammation, fibrin-associated diffuse large B-cell lymphoma (FA-DLBCL), breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and other lymphomas presenting as an effusion...
September 2023: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/37545962/human-herpesvirus-8-infection-in-tunisian-adult-acute-leukemia-patients
#27
JOURNAL ARTICLE
Imene Handous, Naila Hannachi, Bechir Achour, Manel Marzouk, Olfa Hazgui, Saloua Yacoub, Abderrahim Khelif, Jalel Boukadida
BACKGROUND: Human herpesvirus 8 (HHV-8) has been linked to the development of Kaposi's sarcoma (KS)and multiple other hematologic malignant disorders. However, the role of HHV-8 in acute leukemia patients is unknown. OBJECTIVES: The objective of this study was to determine the prevalence of HHV-8 in Tunisian acute leukemia patients and in healthy blood donors. METHODS: An indirect immunofluorescence test was used to detect the presence of anti-HHV8 antibodies...
March 2023: African Health Sciences
https://read.qxmd.com/read/37536670/plasmodium-falciparum-malaria-is-associated-with-increased-kshv-seropositivity-and-higher-kshv-antibody-breadth-and-magnitude-results-of-a-case-control-study-from-rural-uganda
#28
JOURNAL ARTICLE
Angela Nalwoga, Katherine R Sabourin, Wendell Miley, Conner Jackson, Mahdi Maktabi, Nazzarena Labo, Joseph Mugisha, Denise Whitby, Rosemary Rochford, Robert Newton
BACKGROUND: Previously, we showed that children with asymptomatic Plasmodium falciparum (Pf) malaria infection had higher Kaposi sarcoma-associated herpesvirus (KSHV) viral load, increased risk of KSHV seropositivity and higher KSHV antibody levels. We hypothesise that clinical malaria has an even larger association with KSHV seropositivity. Therefore in the current study, we investigated the association between clinical malaria and KSHV seropositivity and antibody levels. METHODS: Between 12/2020 to 03/2022, sick children (aged 5-10 years) presenting at a clinic in Uganda were enrolled in a case-control study...
August 4, 2023: Journal of Infectious Diseases
https://read.qxmd.com/read/37474295/the-role-of-interleukin-6-in-the-pathogenesis-and-therapy-of-castleman-disease-an-immunologist-s-perspective
#29
JOURNAL ARTICLE
Tomáš Milota, Zuzana Střížová, Marta Sobotková, Jiřina Bartůňková
Castleman disease (CD) is a heterogeneous group of diseases characterized by lymphadenopathy and systemic inflammatory manifestations. CD can be divided into uni- (UCD) and multicentric form (MCD) according to the disease extent. MCD is usually accompanied by the features of a systemic inflammatory response including fever, weight loss, hepatosplenomegaly, ascites, and edema. In these patients, we can also observe elevation of inflammatory parameters and anemia within the laboratory assessment. Based on etiological nature, the CD can be further divided into human herpesvirus-8-associated (HHV8-associated) and idiopathic form...
2023: Casopís Lékar̆ů C̆eských
https://read.qxmd.com/read/37391021/cutaneous-findings-in-inborn-errors-of-immunity-an-immunologist-s-perspective
#30
JOURNAL ARTICLE
Deniz Cagdas, Ruveyda Ayasun, Duygu Gulseren, Ozden Sanal, Ilhan Tezcan
Cutaneous manifestations are common in patients with inborn errors of immunity (IEI)/primary immunodeficiency (PID) and could be due to infections, immune dysregulation, or lymphoproliferative/malign diseases. Immunologists accept some as warning signs for underlying inborn errors of immunity. Herein, we include noninfectious/infectious cutaneous manifestations that we come across in rare IEI cases in our clinic and provide a comprehensive literature review. For several skin diseases, the diagnosis is challenging and differential diagnosis is necessary...
June 28, 2023: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/37288720/higher-rate-of-progression-in-hiv-than-in-hiv-patients-after-rituximab-for-hhv8-multicentric-castleman-disease
#31
JOURNAL ARTICLE
Camille Rasmussen, Laurence Gérard, Jehane Fadlallah, Emilie Corvilain, Lionel Galicier, Véronique Meignin, Eric Oksenhendler, David Boutboul
Rituximab has revolutionized the treatment of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-associated multicentric Castleman disease (HHV8+ MCD), converting a rapidly fatal illness into a relapsing disease. HHV8+ MCD mainly affects patients with HIV infection but can also be observed in patients without HIV infection. We retrospectively analyzed a cohort of 99 patients (73 who tested HIV+ and 26 who tested HIV-), with HHV8+ MCD treated with rituximab-based therapy. Baseline characteristics were similar in patients who had HIV- and HIV+ results, although those who tested HIV- were older (65 vs 42 years) and presented less frequently with Kaposi sarcoma (15% vs 40%)...
September 26, 2023: Blood Advances
https://read.qxmd.com/read/37283978/a-national-multicenter-retrospective-study-of-castleman-disease-in-china-implementing-cdcn-criteria
#32
JOURNAL ARTICLE
Lu Zhang, Yu-Jun Dong, Hong-Ling Peng, Hao Li, Ming-Zhi Zhang, Hui-Han Wang, Qin-Hua Liu, Li-Ping Su, Li-Ye Zhong, Wen-Jun Wu, Liang Huang, Xiao-Jing Yan, Lei Fan, Wen-Jiao Tang, Zhen-Ling Li, Lin-Tao Bi, Yan Li, Guang-Xun Gao, Li Gao, Ting-Bo Liu, Yong-Qiang Wei, Yao Liu, Li Yu, Hui Zhou, Chun-Yan Sun, Wen-Bin Qian, De-Hui Zou, Hui-Lai Zhang, Kai-Yang Ding, Xiao-Bo Wang, Ou Bai, Wen-Rong Huang, Bing Chen, Lin Yang, Jia Song, Da Gao, Tong Chen, Jun Luo, Shu-Ye Wang, Liang-Ming Ma, David C Fajgenbaum, Jian Li
BACKGROUND: Castleman disease (CD) is a group of rare and heterogenous lymphoproliferative disorders including unicentric CD (UCD), human herpesvirus-8(HHV-8)-associated multicentric CD (HHV8-MCD), and HHV-8-negative/idiopathic multicentric CD (iMCD). Knowledge of CD mainly comes from case series or retrospective studies, but the inclusion criteria of these studies vary because the Castleman Disease Collaborative Network (CDCN) diagnostic criteria for iMCD and UCD were not available until 2017 and 2020, respectively...
May 2023: The Lancet Regional Health. Western Pacific
https://read.qxmd.com/read/37275431/paraneoplastic-scleroderma-in-kaposi-s-sarcoma-report-of-two-cases
#33
Sara Oulad Ali, Jihane Belcadi, Kaoutar Znati, Marieme Meziane, Nadia Ismaili, Laila Benzekri, Karima Senouci
Kaposi's sarcoma (KS) is a proliferative and multifocal disease with a double vascular and fibroblastic cell component, of mucocutaneous and visceral expression. It is a multifocal tumoral process, hyperplastic in nature without metastatic potential, induced by the human herpes virus 8 (HHV8). Paraneoplastic syndromes (PS) in KS are rare, with only a small number of cases reported and we have found no previous descriptions of a paraneoplastic scleroderma in KS in the literature. We report the cases of two patients with this atypical PS...
June 2023: Skin Health Dis
https://read.qxmd.com/read/37251742/hhv8-unrelated-primary-effusion-lymphoma-in-a-patient-with-hbv-related-liver-cirrhosis-a-case-successfully-treated-with-rituximab-and-lenalidomide
#34
Peng-Jun Liao, Hui Yuan, Xiao-Juan Wei
Human herpesvirus type 8 (HHV-8) unrelated primary effusion lymphoma (PEL) like lymphoma (PEL-LL) is an exceedingly rare non-Hodgkin lymphoma with no characteristic symptoms and consensus on the optimal treatment. This case report presents a 55-year-old man with prior HBV-related Child-Pugh B liver cirrhosis and developing activity-related dyspnea. A moderate amount of pleural effusion was identified without tumor masses, and cytological studies confirmed a diagnosis of PEL-LL. The patient received rituximab and lenalidomide, albeit with HBV infection, and is currently on maintenance therapy with resolving symptoms but without HBV reactivation...
June 2023: Clinical Case Reports
https://read.qxmd.com/read/37180332/hhv8-and-ebv-negative-primary-effusion-based-lymphoma-a-case-report-of-a-new-provisional-entity-and-review-of-literature
#35
Marta Canelo-Vilaseca, Gustavo Tapia, Elisa Orna, Marc Sorigué, Isabel Granada, Azahara Palomar-Muñoz, Ana Castillo, Javier Grau, Alba Mesa, Josep-Maria Ribera, Juan-Manuel Sancho, José-Tomás Navarro
KEY CLINICAL MESSAGE: HHV8- and EBV-negative primary effusion lymphoma is an extremely rare neoplasm involving body cavities without detectable tumor mass. It usually presents in elderly patients without known immunodeficiency. Compared to primary effusion lymphoma, it has a better prognosis. UNLABELLED: Primary effusion lymphoma (PEL) is a rare non-Hodgkin lymphoma confined exclusively to body cavities without detectable tumor masses. The term PEL-like is an entity similar to PEL in clinical presentation but without relation to human herpesvirus 8 (HHV8)...
May 2023: Clinical Case Reports
https://read.qxmd.com/read/37175521/t-cells-subsets-in-castleman-disease-analysis-of-28-cases-including-unicentric-multicentric-and-hhv8-related-clinical-forms
#36
JOURNAL ARTICLE
Sara Fraticelli, Marco Lucioni, Giuseppe Neri, Deborah Marchiori, Caterina Cristinelli, Michele Merli, Rodolfo Monaco, Tiziana Borra, Antonio Lazzaro, Silvia Uccella, Luca Arcaini, Marco Paulli
Castleman disease (CD) is a rare lymphoproliferative disorder that includes various clinico-pathological subtypes. According to clinical course, CD is divided into unicentric CD (UCD) and multicentric CD (MCD). MCD is further distinguished based on the etiological driver in herpes virus-8-related MCD (that can occur in the setting of HIV); in MCD associated with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes); and idiopathic MCD (iMCD). The latter can also be divided in iMCD-TAFRO (thrombocytopenia, anasarca, fever, myelofibrosis, organomegaly) and iMCD not otherwise specified...
April 25, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37150962/extracavitary-primary-effusion-lymphoma-affecting-the-oral-cavity-a-rare-case-report
#37
JOURNAL ARTICLE
Cinthia V B López de Cáceres, Maria S P Sant'Ana, Elena M J Roman Tager, Rommel M R Burbano, Oslei P de Almeida, Pablo A Vargas, Felipe P Fonseca
Primary effusion lymphoma (PEL) is an aggressive neoplasm often diagnosed in immunosuppressed patients demonstrating peritoneal, pleural, or pericardial effusions. This high-grade lymphoma is strongly associated with human herpesvirus 8 (HHV8) infection and most of the lesions also show the presence of Epstein-Barr virus in tumor cells, which lacks CD20 expression and reveals a plasmablastic morphology and phenotype. The extracavitary or solid variant of PEL is even rarer and usually affects the lymph nodes and is currently considered a clinical manifestation of the classic PEL...
May 7, 2023: International Journal of Surgical Pathology
https://read.qxmd.com/read/37111242/oncogenic-viruses-encoded-micrornas-and-their-role-in-the-progression-of-cancer-emerging-targets-for-antiviral-and-anticancer-therapies
#38
REVIEW
Mahmoud Kandeel
Approximately 20% of all cases of human cancer are caused by viral infections. Although a great number of viruses are capable of causing a wide range of tumors in animals, only seven of these viruses have been linked to human malignancies and are presently classified as oncogenic viruses. These include the Epstein-Barr virus (EBV), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV), Merkel cell polyomavirus (MCPyV), human herpesvirus 8 (HHV8), and human T-cell lymphotropic virus type 1 (HTLV-1)...
March 23, 2023: Pharmaceuticals
https://read.qxmd.com/read/37106396/taxonomic-reclassification-of-kaposi-sarcoma-identifies-disease-entities-with-distinct-immunopathogenesis
#39
JOURNAL ARTICLE
M R Openshaw, E Gervasi, C A M Fulgenzi, D J Pinato, A Dalla Pria, M Bower
BACKGROUND: The taxonomy of Kaposi Sarcoma (KS) is based on a classification system focused on the description of clinicopathological features of KS in geographically and clinically diverse populations. The classification includes classic, endemic, epidemic/HIV associated and iatrogenic KS, and KS in men who have sex with men (MSM). We assessed the medical relevance of the current classification of KS and sought clinically useful improvements in KS taxonomy. METHODS: We reviewed the demographic and clinicopathological features of 676 patients with KS, who were referred to the national centre for HIV oncology at Chelsea Westminster hospital between 2000 and 2021...
April 27, 2023: Journal of Translational Medicine
https://read.qxmd.com/read/37080393/anaplastic-kaposi-sarcoma-a-clinicopathologic-and-molecular-genetic-analysis
#40
JOURNAL ARTICLE
Grant M Fischer, Troy J Gliem, Patricia T Greipp, Andrew E Rosenberg, Andrew L Folpe, Jason L Hornick
Kaposi sarcoma (KS) is a human herpesvirus 8 (HHV8)-associated vascular proliferation that most often involves the skin. Rarely, KS shows marked nuclear atypia or pleomorphism; such examples are known as "anaplastic" KS. This poorly characterized variant often pursues an aggressive course; little is known of its genetic landscape. This study evaluated the clinicopathologic and genomic features of anaplastic KS. We identified 9 anaplastic KS cases from 7 patients and 8 conventional KS cases, including a matched conventional KS and primary metastasis anaplastic KS pair from a single patient (anaplastic KS diagnosed 9 years after conventional KS)...
August 2023: Modern Pathology
keyword
keyword
82616
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.